SOUTH SAN FRANCISCO, Calif., April 17, 2019 /PRNewswire/ -- NAVAN Technologies, Inc. (NAVAN), a privately-held biotechnology company enabling scalable cell and gene therapies through a novel, proprietary NanoStraw platform, announced today that Michael J. Nowak, Ph.D., President and Chief ...
For more information, please visit
https://www.prnewswire.com:443/news-rele[...]e-mediterranean-300834318.html